Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3124 ARTÍCULOS , VIENDO DEL 1 AL 15

Natural Terpenoids as Neuroinflammatory Inhibitors in LPS-stimulated BV-2 Microglia

Xu Y, Wei H, Gao J.

Mini Rev Med Chem. 2021;21(4):520-534. doi: 10.2174/1389557519666190611124539.

The Design and Application of an Appropriate Parkinson's Disease Animal Model in Regenerative Medicine

Larijani B, Goodarzi P, Payab M, Tayanloo-Beik A, Sarvari M, Gholami M, Gilany K, Nasli-Esfahani E, Yarahmadi M, Ghaderi F, Arjmand B.

Adv Exp Med Biol. 2021;1341:89-105. doi: 10.1007/5584_2019_422.

Metastatic Malignant Melanoma to the Cavernous Sinus: A Case of Recurrent Disease Presenting as Parkinson Syndrome

Dryden SC, Kudrna JJ, Thompson BN, Patel RB, Choudhri AF, Ditta LC.

J Neuroophthalmol. 2021 Mar 1;41(1):e89-e90. doi: 10.1097/WNO.0000000000000886.

Recent Advances in c-Jun N-Terminal Kinase (JNK) Inhibitors

Li G, Qi W, Li X, Zhao J, Luo M, Chen J.

Curr Med Chem. 2021;28(3):607-627. doi: 10.2174/0929867327666200210144114.

Melatonin Receptor as a Drug Target for Neuroprotection

Wongprayoon P, Govitrapong P.

Curr Mol Pharmacol. 2021;14(2):150-164. doi: 10.2174/1874467213666200421160835.

mHealth Technologies Towards Parkinson's Disease Detection and Monitoring in Daily Life: A Comprehensive Review

Zhang H, Song C, Rathore AS, Huang MC, Zhang Y, Xu W.

IEEE Rev Biomed Eng. 2021;14:71-81. doi: 10.1109/RBME.2020.2991813. Epub 2021 Jan 22.

Effects of Mulberry on The Central Nervous System: A Literature Review

Tam DNH, Nam NH, Elhady MT, Tran L, Hassan OG, Sadik M, Tien PTM, Elshafei GA, Huy NT.

Curr Neuropharmacol. 2021;19(2):193-219. doi: 10.2174/1570159X18666200507081531.

Addressing Manufacturing Challenges for Commercialization of iPSC-Based Therapies

Dashtban M, Panchalingam KM, Shafa M, Ahmadian Baghbaderani B.

Methods Mol Biol. 2021;2286:179-198. doi: 10.1007/7651_2020_288.

Green Tea, A Medicinal Food with Promising Neurological Benefits

Akbarialiabad H, Dahroud MD, Khazaei MM, Razmeh S, Zarshenas MM.

Curr Neuropharmacol. 2021;19(3):349-359. doi: 10.2174/1570159X18666200529152625.

Effects of Deep Brain Stimulation and Dopaminergic Medication on Excitatory and Inhibitory Spinal Pathways in Parkinson Disease

Andrews JC, Roy FD, Stein RB, Ba F, Sankar T.

J Clin Neurophysiol. 2021 Jul 1;38(4):340-345. doi: 10.1097/WNP.0000000000000697.

Progress and Promise of Nur77-based Therapeutics for Central Nervous System Disorders

Liu L, Ma D, Zhuo L, Pang X, You J, Feng J.

Curr Neuropharmacol. 2021;19(4):486-497. doi: 10.2174/1570159X18666200606231723.

Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease

Kaur G, Behl T, Bungau S, Kumar A, Uddin MS, Mehta V, Zengin G, Mathew B, Shah MA, Arora S.

Curr Neuropharmacol. 2021;19(2):233-247. doi: 10.2174/1570159X18666200606233050.

The role of the microbiota-gut-brain axis in neuropsychiatric disorders

Generoso JS, Giridharan VV, Lee J, Macedo D, Barichello T.

Braz J Psychiatry. 2021 May-Jun;43(3):293-305. doi: 10.1590/1516-4446-2020-0987.

Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases

Rahman MH, Akter R, Kamal MA.

CNS Neurol Disord Drug Targets. 2021;20(8):694-703. doi: 10.2174/1871527319666200722153611.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias